Blood pressure drug limits cigarette smoke-induced lung injury in mice

Chronic obstructive pulmonary disease (COPD) is among the most common causes of death in the US. It is a smoking-related disease for which there are currently no disease-altering therapies. However, hope that one could be developed is now provided by the work of Enid Neptune and colleagues, at Johns Hopkins University, Baltimore, in a mouse model of lung disease caused by exposure to cigarette smoke.

Neptune and colleagues found that lostartan, a drug used widely in the clinic (e.g., to treat ), reduced lung disease in mice caused by exposure to .

Losartan blocks the protein angiotensin receptor type 1, and its effects on cigarette smoke–induced lung injury were a result of the fact that blocking angiotensin receptor type 1 leads to a decrease in levels of the soluble molecule TGF-beta.

The authors therefore suggest that other TGF-beta–targeted therapeutics might also be viable candidates for the treatment of COPD.

More information: Angiotensin receptor blockade attenuates cigarette smoke–induced lung injury and rescues lung architecture in mice, Journal of Clinical Investigation.

add to favorites email to friend print save as pdf

Related Stories

Addressing how cigarettes cause cardiovascular disease

Oct 10, 2011

Although cigarette smoking has long been linked to cardiovascular disease, scientists are still on the lookout for insights into how smoking causes this disease. A team of researchers at Pacific Northwest ...

Body's defenses may worsen chronic lung diseases in smokers

Feb 09, 2009

Although the immune system is designed to protect the body from harm, it may actually worsen one of the most difficult-to-treat respiratory diseases: chronic obstructive pulmonary disorder (COPD), according to new University ...

New technique reduces tobacco smoke damage to lungs in mice

Mar 18, 2010

Researchers in Australia have demonstrated that blocking a certain protein can reduce or prevent cigarette smoke-induced lung inflammation in mice. Inflammation underlies the disease process of chronic obstructive pulmonary ...

Recommended for you

The impact of bacteria in our guts

12 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

12 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

13 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments